Peptides by goal · Sleep, focus and mood
Peptides for sleep, ranked by evidence
Checked against our library and study pagesPublished by PepVault
Of the 10 compounds in our library linked to sleep, 6 have been studied in people for it, none has animal or lab evidence only, and 4 rest on community reports alone. DSIP ranks first, with 4 of our study pages in people on sleep.
Peptides and sleep
Deeper sleep is one of the most common reasons people try peptides, and one of the first changes users report with the growth hormone peptides. Very few of these compounds have been studied for sleep itself, so most of what sits on this page is community reports rather than trials.
For sleep, a trial that measured sleep in a lab is worth more than a report of vivid dreams or feeling rested, which are real to the person but hard to compare.

The 10 compounds, ranked by evidence
Studied in people
6 compounds
DSIP
#1 · Human studiesA neuropeptide named for deepening sleep: it boosted deep-sleep (delta) brain waves in rabbits, though small human trials found weak or no sleep benefit and no effect on cortisol. Commonly reported: mixed, with some describing deeper sleep and vivid dreams while many notice nothing, and morning grogginess at higher doses. For sleep it has been studied in people: 4 of our study pages in people are about it.
DSIP gave only weak sleep gains in 16 people with chronic insomniaOur study page: randomized trial in people, 16 people, 1992
- DSIP improved night sleep and daytime alertness in chronic insomnia
- DSIP: longer, less interrupted sleep in 6 people with chronic insomnia
- DSIP: median sleep time up 59% vs placebo in healthy volunteers
Why it is here: its library entry lists “Deep sleep” and “Sleep reset” and 4 of our study pages are about this goal.
Tirzepatide
#2 · Human studiesThe first dual GIP/GLP-1 receptor agonist: it activates two gut-hormone pathways at once, and in a head-to-head trial it produced more weight loss than semaglutide (20.2% vs 13.7% at 72 weeks). FDA-approved for diabetes (Mounjaro) and for weight management and sleep apnea (Zepbound). For sleep it has been studied in people: 1 of our study pages in people is about it.
Tirzepatide: better sleep and quality of life scores in SURMOUNT-OSAOur study page: randomized trial in people, 2025
Why it is here: 1 of our study pages is about this goal.
Epitalon
#3 · Human studiesA synthetic peptide modeled on a pineal gland extract from Russian longevity research. Commonly reported: deeper sleep and more vivid dreams during a cycle, with little else to feel. For sleep it has been studied in people: 1 of our study pages in people is about it.
Epitalon: night melatonin rose in elderly with low pineal functionOur study page: randomized trial in people, 2004
Why it is here: its library entry lists “Sleep quality” and 1 of our study pages is about this goal.
GHRP-6
#4 · Human studiesOne of the first growth hormone releasing peptides, with one standout effect: strong appetite stimulation. For sleep it has been studied in people: 1 of our study pages in people is about it.
GHRP-6 raised night GH, ACTH, cortisol and stage 2 sleep in menOur study page: randomized trial in people, 1995
Why it is here: 1 of our study pages is about this goal.
Hexarelin
#5 · Human studiesOne of the most powerful GH secretagogues, with a catch: the response fades. For sleep it has been studied in people: 1 of our study pages in people is about it.
Hexarelin cut deep sleep and raised GH, ACTH, cortisol, prolactinOur study page: clinical trial in people, 2004
Why it is here: 1 of our study pages is about this goal.
MK-677
#6 · Human studiesNot actually a peptide — it's a small molecule you take orally that mimics ghrelin to stimulate GH release. Commonly reported: strong hunger, especially in the first weeks; water retention with puffy hands and feet or tingling hands; and deeper sleep with vivid dreams, sometimes with morning grogginess. For sleep it has been studied in people: 1 of our study pages in people is about it.
MK-677: about 50% more stage IV sleep in young adults on 25 mgOur study page: clinical trial in people, 1997
Why it is here: its library entry lists “Sleep quality” and 1 of our study pages is about this goal.
Community reports only
4 compounds
Sermorelin
#7 · Reports onlyA synthetic copy of the first 29 amino acids of your natural growth hormone releasing hormone: it prompts your pituitary to release its own GH, keeping the body's feedback loops in play. Commonly reported: deeper sleep and vivid dreams in the first weeks, with gentle, slow-building effects, milder than CJC/ipamorelin. For sleep it rests on community reports: no study page of ours covers this goal, and the library lists it under “Sleep”.
Why it is here: its library entry lists “Sleep”.
CJC-1295 no DAC
#8 · Reports onlyThe shorter-acting version of CJC-1295, meant to give sharp, pulse-like GH release. Commonly reported: a flush or head rush within minutes of injecting, deeper sleep and vivid dreams early on, and mild water retention over the weeks. For sleep it rests on community reports: no study page of ours covers this goal, and the library lists it under “Sleep”.
Why it is here: its library entry lists “Sleep”.
Ipamorelin
#9 · Reports onlyConsidered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides. Commonly reported: deeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. For sleep it rests on community reports: no study page of ours covers this goal, and the library lists it under “Sleep quality”.
Why it is here: its library entry lists “Sleep quality”.
Pinealon
#10 · Reports onlyA short synthetic peptide from the Russian bioregulator program, designed from brain-tissue extracts (not pineal tissue, despite the name). Commonly reported: vivid dreams and deeper sleep, and clearer thinking during the cycle. For sleep it rests on community reports: no study page of ours covers this goal, and the library lists it under “Sleep”.
Why it is here: its library entry lists “Sleep”.
How they differ
Route, dosing frequency and half-life as each library entry records them, for the 10 compounds in ranked order.
| Compound | Evidence | Route | Dosing frequency | Half-life |
|---|---|---|---|---|
| DSIP | Human studies | SubQ injection | Nightly or as needed 30-60 min before sleep. Short cycles of 5-10 days. | Short |
| Tirzepatide | Human studies | SubQ injection | Weekly | ~5 days |
| Epitalon | Human studies | SubQ injection, IM injection | Daily for 10–20 day cycles | Short |
| GHRP-6 | Human studies | SubQ injection | 2–3x daily | ~20 min |
| Hexarelin | Human studies | SubQ injection | 2–3x daily | ~55–70 min |
| MK-677 | Human studies | Oral | Daily, before bed | ~24 hours |
| Sermorelin | Reports only | SubQ injection | Daily, before bed | ~11–12 min |
| CJC-1295 no DAC | Reports only | SubQ injection | 2–3x daily | ~30 min |
| Ipamorelin | Reports only | SubQ injection, IM injection | 2–3x daily, best fasted or before bed | ~2 hours |
| Pinealon | Reports only | SubQ injection, Nasal | Daily for 10–20 day cycles, 2–3 cycles per year | Short |
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Nightly or as needed 30-60 min before sleep. Short cycles of 5-10 days.
- Half-life
- Short
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Weekly
- Half-life
- ~5 days
- Evidence
- Human studies
- Route
- SubQ injection, IM injection
- Dosing
- Daily for 10–20 day cycles
- Half-life
- Short
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- 2–3x daily
- Half-life
- ~20 min
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- 2–3x daily
- Half-life
- ~55–70 min
- Evidence
- Human studies
- Route
- Oral
- Dosing
- Daily, before bed
- Half-life
- ~24 hours
- Evidence
- Reports only
- Route
- SubQ injection
- Dosing
- Daily, before bed
- Half-life
- ~11–12 min
- Evidence
- Reports only
- Route
- SubQ injection
- Dosing
- 2–3x daily
- Half-life
- ~30 min
- Evidence
- Reports only
- Route
- SubQ injection, IM injection
- Dosing
- 2–3x daily, best fasted or before bed
- Half-life
- ~2 hours
- Evidence
- Reports only
- Route
- SubQ injection, Nasal
- Dosing
- Daily for 10–20 day cycles, 2–3 cycles per year
- Half-life
- Short
Compared side by side
Questions
Which peptides have been studied in people for sleep?
6 of the 10 on this page: DSIP, Tirzepatide, Epitalon, GHRP-6, Hexarelin and MK-677. The rest have animal or lab evidence or community reports only.
Is any peptide FDA-approved for sleep?
No. None of the 10 compounds on this page has an FDA approval for a use related to sleep in its library entry.
Which is the best-studied peptide for sleep?
By our count, DSIP, with 4 study pages in people about sleep, the most of any compound here.
Which ones have only animal or lab evidence for sleep?
None: every compound on this page has either human evidence for sleep or community reports only.
How are the peptides for sleep taken?
Of the 10 compounds for sleep, 9 are taken by injection, 1 by mouth, 1 as a nasal spray, as their library entries list (some have more than one route). The table above gives each one’s route, how often it is dosed and its half-life.
How do the peptides for sleep compare with each other?
We compare 9 pairs of them side by side: CJC-1295 no DAC vs Ipamorelin, Ipamorelin vs Sermorelin, Ipamorelin vs MK-677, Ipamorelin vs GHRP-6, Ipamorelin vs Hexarelin, CJC-1295 no DAC vs Sermorelin, MK-677 vs CJC-1295 no DAC, Epitalon vs Pinealon and Epitalon vs DSIP.
How we ranked them
Each compound is placed on the highest rung its evidence for this goal reaches. First come compounds the FDA has approved for a use related to the goal, and only where the library entry says so. Next come compounds studied in people for it (in one of our study pages, or in the trials a research note of the library entry rests on), then those with animal or lab studies only, and last those resting on community reports alone.
Within a rung, compounds are ordered by how many of our study pages in people cover the goal, then by the library’s overall research rating, then by the number of study pages of any kind. A compound is on this page only because its library entry lists a use for this goal, says so in its description, or one of our study pages is about it; the reason is printed with each one.
This is a ranking of evidence, not of results, and not advice on what anyone should take.